CoChat

Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex

Open access
Newman, Lori A., Darling, Jenna, McGaughy, Jill · 2008 · Psychopharmacology

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Background The majority of studies assessing executive function in attention deficit disorder (ADD) have shown deficits in attentional set shifting using either the Wisconsin card sorting task or the intra-dimensional/extra-dimensional set-shifting task (ID/ED). Damage to the prefrontal cortex in humans, primates, and rodents impairs extra-dimensional (ED) shifts. Noradrenergic depletion of the medial prefrontal cortex in rats is sufficient to impair attentional set shifting. Atomoxetine, a selective norepinephrine (NE) re-uptake inhibitor, is hypothesized to produce beneficial effects in patient with ADD by augmenting NE release in prefrontal cortex.Materials and methods We assessed the effects of systemic administration of atomoxetine (0.0, 0.1, 0.3, and 0.9 mg/kg/ml) in normal and noradrenergically lesioned (NE-LX) rats on attentional-set shifts. We replicated findings showing NE-LX rats are selectively impaired on the ED shifts but not reversals or other discriminations.Results Atomoxetine remediated the attentional set-shifting impairments in NE-LX rats but impaired ED performance of non-lesioned rats.Discussion Though atomoxetine is neurochemically selective, it is not wholly specific at doses >0.3 mg/kg. All doses of the drug were similar in their efficacy in reversing the ED deficit, but the effectiveness of the 0.1 mg/kg dose supports the hypothesis that increases in prefrontal NE alone are sufficient to improve attention in NE-LX rats. Moreover, the detrimental effects of the drug in non-lesioned rats support the hypothesis that optimal levels of NE in prefrontal cortex are critical to attentional set shifting with both supra- and sub-optimal levels producing attentional impairments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-008-1097-8

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 1

  1. Tait D, McGaughy J, Latimer MP, Brown V (2002) 192 IgG-saporin lesions of the cholinergic basal forebrain do not impair attentional set-shifting, but do increase latency to dig. Proceedings of the Society for Neuroscience, New Orleans, LA

Cited by

See all 137

Metadata

Authors
Newman, L. A., Darling, J., & McGaughy, J.
Affiliations
University of New Hampshire (US)
Corresponding author
McGaughy, Jill
Venue
Psychopharmacology
Published
2008-06-22
Volume
200
Issue
1
Pages
39-50
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2034057430
Cited by
137
References
77
Citations by year
2026: 5 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 8
FWCI
7.73
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (R21MH087921)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
atomoxetine, medial prefrontal cortex, set-shifting, norepinephrine reuptake inhibition, attention deficit disorder, executive function, dose-dependent effects
MeSH terms
Atomoxetine Hydrochloride, Animals, Attention, Attention Deficit Disorder with Hyperactivity, Behavior, Animal, Discrimination Learning, Disease Models, Animal, Dose-Response Relationship, Drug, Norepinephrine, Propylamines, Psychomotor Performance, Prefrontal Cortex, Adrenergic Uptake Inhibitors, Rats, Long-Evans, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. https://app.cochat.ai/papers/10.1007/s00213-008-1097-8
The paper
Newman, L. A., Darling, J., & McGaughy, J. (2008). Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology. https://doi.org/10.1007/s00213-008-1097-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.